Capricor Therapeutics (CAPR) Share-based Compensation Growth (3y) (2013 - 2026)
Capricor Therapeutics (CAPR) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
4.80% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
39.19% |
| Date | Value |
|---|
| Mar 31, 2026 |
39.19% |
| Dec 31, 2025 |
49.56% |
| Sep 30, 2025 |
54.35% |
| Jun 30, 2025 |
97.14% |
| Mar 31, 2025 |
-37.71% |
| Dec 31, 2024 |
43.30% |
| Sep 30, 2024 |
41.75% |
| Jun 30, 2024 |
44.58% |
| Mar 31, 2024 |
63.08% |
| Dec 31, 2023 |
57.81% |
| Sep 30, 2023 |
52.23% |
| Jun 30, 2023 |
31.97% |
| Mar 31, 2023 |
96.83% |
| Dec 31, 2022 |
107.60% |
| Sep 30, 2022 |
68.99% |
| Jun 30, 2022 |
110.46% |
| Mar 31, 2022 |
68.38% |
| Dec 31, 2021 |
25.91% |
| Sep 30, 2021 |
18.72% |
| Jun 30, 2021 |
18.95% |
